Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Implantable sustained-release cisplatin in advanced esophageal cancer
CTR20150801Phase 3Active
- Sponsor
- Anhui Zhongren Technology
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Anhui Zhongren Technology. Started Dec 2015; status: active.
02
Drugs
cisplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on CTR20150801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150801.